[go: up one dir, main page]

Akkaramongkolporn et al., 2003 - Google Patents

Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration

Akkaramongkolporn et al., 2003

View PDF
Document ID
16801638991723851668
Author
Akkaramongkolporn P
Ngawhirunpat T
Publication year
Publication venue
Die Pharmazie-An International Journal of Pharmaceutical Sciences

External Links

Snippet

Two classical resinates, ambroxal (AMX) resinate and chlorpheniramine (CPM) resinate, and a novel formulation of dual AMX and CPM resinate were prepared by the batch method. The dissolution behavior of the drug from the classical resinates, a mixture of two classical …
Continue reading at www.ingentaconnect.com (PDF) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48176Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly(meth)acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol

Similar Documents

Publication Publication Date Title
RU2256442C2 (en) Consumed film for in-mouth holding and a method for preparation of consumed film
US12201720B2 (en) Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release
ES2254274T3 (en) HYDROGEL HETERODISPERSOS SYSTEMS OF SUSTAINED LIBERATION FOR INSOLUBLE PHARMACOS.
Guo et al. Ion-exchange resins as drug delivery carriers
EP2694038B1 (en) Pharmaceutical composition
US20080081072A1 (en) Resin-complex granulation for water-soluble drugs and associated methods
US4721709A (en) Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
CN102885798B (en) Orally disintegrating tablet
Shukla et al. Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets
PL175814B1 (en) Solid dosed form of prolonged release for oral administration and method of obtaining same,
HU218661B (en) A method for the preparation of pharmaceutical forms comprising a complex of pharmaceutically active ionic drug and ion exchange resin
EP0367746A2 (en) Sustained release drug-resin complexes
SA01210741B1 (en) Stable extended release oral dogase composition
PL194526B1 (en) Improved fast disintegrating tablet
HU227381B1 (en) Pharmaceutical composition containing slightly water-soluble drugs with immediate release core and instained release coating
JP2002534374A (en) Multiparticulate oral dosage form
JPS63165318A (en) Light-stable nifedipin concentrate and manufacture
DE69419281T2 (en) Flavor-masked solid preparation and manufacturing method
Lorenzo-Lamosam et al. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers
US4780322A (en) Method of producing slow-release pharmaceutical forms
Akkaramongkolporn et al. Dual ambroxal and chlorpheniramine resinate as an alternative carrier in concurrent resinate administration
KR20050082038A (en) Tamsulosin hydrochloride composition for oral administration and controlled-release granule formulation thereof
JPH05504574A (en) Composition
JPS609697B2 (en) formulation
Pisal et al. Drug release properties of polyethylene-glycol-treated ciprofloxacin-Indion 234 complexes